| 151 |
17106061 | Thiazolidinediones improve beta-cell function in type 2 diabetic patients. | 2007 Mar |
1 |
| 152 |
17148569 | Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes. | 2007 Feb |
1 |
| 153 |
17161222 | Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone. | 2007 Jan |
2 |
| 154 |
17174222 | A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes. | 2007 Jan |
5 |
| 155 |
17189867 | Rosiglitazone: safety and efficacy in combination with insulin in poorly controlled type 2 diabetes mellitus patients treated with insulin alone. | 2007 Jan-Feb |
2 |
| 156 |
17200362 | Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers. | 2007 Jan 1 |
2 |
| 157 |
17224000 | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. | 2007 Feb |
1 |
| 158 |
17287417 | Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. | 2007 Feb |
2 |
| 159 |
17303006 | Insulin-sensitizing effects of a novel alpha-methyl- alpha -phenoxylpropionate derivative in vitro. | 2007 Mar |
1 |
| 160 |
17310221 | Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. | 2007 Aug |
2 |
| 161 |
17331860 | Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus. | 2007 Mar-Apr |
1 |
| 162 |
17339547 | Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. | 2007 Mar 13 |
1 |
| 163 |
17403121 | A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes. | 2007 Jun |
3 |
| 164 |
17403436 | The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. | 2007 Apr |
1 |
| 165 |
17486315 | Direct rosiglitazone-induced modifications in insulin secretion, action and clearance: a single-dose hyperglycaemic clamp study. | 2007 Jul |
6 |
| 166 |
17555498 | Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue. | 2007 Sep |
3 |
| 167 |
17580731 | Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination. | 2007 |
1 |
| 168 |
17592102 | Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes. | 2007 Jun 25 |
2 |
| 169 |
17612907 | Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance. | 2007 |
2 |
| 170 |
17636829 | Interventions for latent autoimmune diabetes (LADA) in adults. | 2007 Jul 18 |
2 |
| 171 |
17654601 | Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. | 2007 Aug |
2 |
| 172 |
17705694 | The effect of rosiglitazone on orthostatic tolerance during heat exposure in individuals with type II diabetes. | 2007 Aug |
1 |
| 173 |
17785501 | Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. | 2007 Nov |
1 |
| 174 |
17889553 | The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. | 2007 Oct |
4 |
| 175 |
17890427 | A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus. | 2007 Nov |
3 |
| 176 |
17892035 | [The effect of rosiglitazone on plasma adiponectin and resistin levels in obese PCO woman--preliminary report]. | 2007 |
1 |
| 177 |
18004308 | Thiazolidinediones: a novel class of drugs for the prevention of diabetic nephropathy? | 2007 Dec |
1 |
| 178 |
18038714 | Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome. | 2007 Sep |
2 |
| 179 |
18048112 | [Clinical utilization of combined rosiglitazone and glimepiride in the treatment of type 2 diabetes mellitus]. | 2007 Dec 9 |
1 |
| 180 |
18048467 | Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. | 2007 Nov |
1 |
| 181 |
18062722 | Rosiglitazone : a review of its use in type 2 diabetes mellitus. | 2007 |
1 |
| 182 |
18074413 | Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial. | 2007 Dec |
7 |
| 183 |
18220657 | The anti-atherogenic effects of thiazolidinediones. | 2007 Feb |
2 |
| 184 |
19888409 | Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. | 2007 Mar |
2 |
| 185 |
16155076 | Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. | 2006 Jan |
4 |
| 186 |
16199428 | Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance. | 2006 Jan |
3 |
| 187 |
16324915 | Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride. | 2006 Jan |
3 |
| 188 |
16352689 | The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes. | 2006 Mar |
2 |
| 189 |
16360262 | Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome. | 2006 May 1 |
2 |
| 190 |
16367882 | Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study. | 2006 Jan |
1 |
| 191 |
16367888 | Effects of metformin and oleic acid on adipocyte expression of resistin. | 2006 Jan |
1 |
| 192 |
16369466 | The impact of rosiglitazone on cardiovascular responses and endurance during isometric exercise in patients with Type 2 diabetes. | 2006 Jan |
1 |
| 193 |
16384852 | Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment. | 2006 Apr |
1 |
| 194 |
16444435 | The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus. | 2006 Jan |
2 |
| 195 |
16501039 | Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study. | 2006 Jun |
3 |
| 196 |
16505510 | Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects. | 2006 Mar |
2 |
| 197 |
16546473 | Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein. | 2006 Apr |
2 |
| 198 |
16682454 | A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties. | 2006 Aug |
2 |
| 199 |
16719233 | Impact of rosiglitazone on glycaemic control, insulin levels and blood pressure values in patients with type 2 diabetes. | 2006 |
2 |
| 200 |
16751941 | [Effects of rosiglitazone on endothelial function in non-diabetic subjects with metabolic syndrome]. | 2006 May |
2 |